Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 08-03-2017, 11:58 PM #1
dan1000 dan1000 is offline
Junior Member
 
Join Date: Jul 2016
Posts: 34
5 yr Member
dan1000 dan1000 is offline
Junior Member
 
Join Date: Jul 2016
Posts: 34
5 yr Member
Default Exenatide supposedly stopped Parkinson's degeneration

We may finally be able to slow Parkinson's, with a diabetes drug | New Scientist
dan1000 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (08-04-2017), jeffreyn (08-04-2017), lab rat (08-04-2017), toyL (11-12-2019), Tupelo3 (08-04-2017)

advertisement
Old 08-04-2017, 07:22 AM #2
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Thanks Dan. This is the link for CPT's press release with a little more info:
Cure Parkinson's Trust | Breaking News: Diabetes Drug Shows Potential as Disease-Modifying Therapy for Parkinson’s

I received the the full publication last evening but haven't had a chance to review it yet (I will over the weekend). I would be happy to email to anyone who is interested.

Gary
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (08-04-2017), jeffreyn (08-04-2017), lab rat (08-04-2017), soccertese (08-08-2017)
Old 08-04-2017, 07:32 AM #3
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

My only quibble is the use of the word "stopped" (i.e. it's a bit too strong). In the title of the article they use the words "may" and "slow".

Also, in the abstract of the research paper they say [1]:

"Whether exenatide affects the underlying disease pathophysiology or simply induces long-lasting symptomatic effects is uncertain."

[1] Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial, Athauda et al., The Lancet, 03 August 2017.
http://www.thelancet.com/journals/la...585-4/fulltext
jeffreyn is offline   Reply With QuoteReply With Quote
Old 08-05-2017, 07:40 PM #4
olsen's Avatar
olsen olsen is offline
Senior Member
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
Default earlier discussion of exenatide (Byetta)

Drug was first ok'ed by the FDA in 2005.
Byetta (diabetes drug) Cures Parkinson's Disease in Rats
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here — it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (08-05-2017)
Old 08-05-2017, 11:29 PM #5
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default

A couple of good write-ups (IMHO) on the exenatide trial, from the SoPD blog and from Parkinson's UK.

Exenatide: One step closer to joblessness! | The Science of Parkinson's disease

Exenatide — latest trial results explained – Parkinson’s UK – Medium
jeffreyn is offline   Reply With QuoteReply With Quote
Old 08-06-2017, 05:40 AM #6
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

In my opinion, although hoping for the best, we should be cautious about how we interpret these results.

The Cure Parkinson's Trust report says [1]:

"The participants did not report noticeable improvements in their symptoms during the trial period beyond what their standard medication already did for them."

Although progression is usually slow in PD, one would still have expected some comments along the lines of "I've had a good year". This raises the question of whether the MDS-UPDRS is the correct measure to use for assessing the efficacy of progression slowing drugs. In my opinion, there is too low a priority given to non-motor symptoms.

The "Science of Parkinson's disease" gives graphs of the results [2]. Even at face value, the size of the changes are small: after 48 weeks, the difference between the placebo group and the Exenatide group is only about 4 points on the MDS-UPDRS part III scale, motor examination [3]. Part III adds 33 scores each of 0, 1, 2, 3, 4, giving a total score of from 0 (good) to 132 (bad).

The Exenatide graph show a steep improvement from the baseline at time 0 to the next measure after 12 weeks of taking the drug, a fairly flat performance during weeks 12 to 48 where the drug is taken throughout, followed with a decline in performance once the drug is removed. This may indicate not a slowing of progression but, rather, a symptomatic effect.

Tupelo3, I'll be grateful if you could point me to the full paper.

References:

[1] Cure Parkinson's Trust | Breaking News: Diabetes Drug Shows Potential as Disease-Modifying Therapy for Parkinson’s

[2] Exenatide: One step closer to joblessness! | The Science of Parkinson's disease

[3] Rehab Measures - Movement Disorder Society sponsored Unified...

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
jeffreyn (08-06-2017), lab rat (08-06-2017), soccertese (08-10-2017), Tupelo3 (08-06-2017)
Old 08-06-2017, 11:58 AM #7
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by johnt View Post
In my opinion, although hoping for the best, we should be cautious about how we interpret these results.

John
The reviews posted by everyone above are as good as you can find, so I don't think I need to add much more. I do agree that we need to be positive, but cautious, about these results, no different than any other small phase two study.

That being said, I'm not as concerned as others about the relatively small difference, which was statistically significant, between the groups. Exenatide is believed to slow PD progression more so than reverse it. One year is not that much time in the normal progression of PD symptoms. Just think about how each of us vary from day to day. I don't think any of us would notice a two point UPDRS improvement or decline. I think the mild improvement in the test group compared to the mild deterioration in the placebo group is about all you could have hoped for over the course of one year. I also think that difference, along with the important DatScan results, is "indicative" of the drug effect being neuroprotective rather than just symptomatic. I would imagine that the Phase 3 trial, which will happen sometime in the future, will be longer term. It will probably be in the range of three years, like the design of the current ongoing Isradipine trial. Unfortunately, that's the time that is needed to see meaningful differences in progression compared to a placebo.


Gary
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (08-07-2017), jeffreyn (08-06-2017), lab rat (08-06-2017), RooJr (08-08-2017), soccertese (08-08-2017)
Old 08-08-2017, 09:44 PM #8
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default More write-ups!

and just when you thought it was safe to get back in the water ...

A couple more exenatide write-ups!

The SoPD blog has had another go at it, and the researchers have written an open-access editorial.

Exenatide: An editorial | The Science of Parkinson's disease

Is Exenatide a Treatment for Parkinson’s Disease? - IOS Press
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
johnt (08-09-2017)
Old 08-09-2017, 06:02 PM #9
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
10 yr Member
Default

What is the relationship between alpha-synuclein and Exenatide?

Given the supposed centrality of alpha-synuclein in the pathogenesis of PD, you would expect any treatment which slowed the progression of PD to involve alpha-synuclein in some way.

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
Old 06-14-2018, 03:00 AM #10
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
5 yr Member
Default Exenatide update

Quite a bit has happened since we last discussed exenatide.

This recent post on the SoPD blog can help bring us all up to date. :-)

What do you do with a problem like Exenatide?:
What do you do with a problem like Exenatide? | The Science of Parkinson's
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
kiwi33 (06-14-2018)
Reply

Tags
degeneration, exenatide, parkinsons, stopped, supposedly

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
sept2 commentary - Is Exenatide the Next Big Thing in Parkinson’s Disease? - rehash soccertese Parkinson's Disease 2 10-05-2014 12:59 PM
june article, Exenatide and the treatment of patients with Parkinson’s disease soccertese Parkinson's Disease 5 05-07-2014 01:23 PM
hadn't seen this - Creatine LS-1 Study in Parkinson's Disease Stopped by NINDS soccertese Parkinson's Disease 1 09-27-2013 09:53 AM
Parkinson's disease stopped in animal model !! sim00 Parkinson's Disease 4 11-16-2012 11:21 PM
Supposedly Nerve Damage? insilverscript Medications & Treatments 2 12-07-2011 12:29 PM


All times are GMT -5. The time now is 02:58 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.